Medical Research Institute of New Zealand
MRINZ is an independent, non-profit clinical research organisation based in Wellington, New Zealand, founded in 2001. It conducts investigator-initiated clinical trials in respiratory medicine, critical care, infectious diseases, and stroke rehabilitation across 11 countries, funded by the Health Research Council of New Zealand, Cure Kids, and industry partners.
- Company typePrivate
- Founded2001
- HeadquartersWellington, New Zealand
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Medical Research Institute of New Zealand does
The Medical Research Institute of New Zealand (MRINZ) is an independent, non-profit clinical research organisation founded in 2001 in Wellington, New Zealand, and registered as a charity (CC22439). It conducts investigator-initiated and collaborative clinical trials across respiratory medicine (asthma, COPD), critical care, infectious diseases, stroke rehabilitation, and pharmacy research, with active programmes spanning 11 collaborating countries. Core operational assets include the Pharmacy Research Network (25 NZ sites), 63 collaborating practice sites, and international ICU infrastructure (137 ICUs across 14 countries via the Mega-ROX trial). MRINZ has produced over 1,000 peer-reviewed publications at an average of 75 per year, with findings published in The Lancet, NEJM, and Lancet Respiratory Medicine that have influenced international treatment guidelines.
MRINZ's commercial output is research evidence and a limited number of clinical interventions rather than licensed products. Notable programme outputs include the Take Charge Stroke Rehabilitation Intervention (a free, multi-language patient-centred tool), the AIR (Anti-Inflammatory Reliever) Therapy evidence base showing 45-55% reduction in asthma exacerbations with budesonide/formoterol reliever therapy, and the automated oxygen control evidence base showing 96% time within target saturation range versus 71% with manual titration. The recently funded HRC AI-ICU research programme marks the institute's first major AI-led research vertical.
The business model is grant-funded rather than commercial. Revenue (undisclosed) is sourced primarily from the Health Research Council of New Zealand, Cure Kids, and a small set of industry partners including Fisher & Paykel Healthcare and AstraZeneca, supplemented by donations and academic partnerships with Victoria University of Wellington, University of Otago, Western Sydney University, Imperial College London, Montpellier University, and the University of Groningen. The institute operates with 11-50 employees and has no parent company, no subsidiaries, and no public listing. Its charitable, autonomous status is structurally central to its value proposition: it enables independent, investigator-led research without commercial sponsor pressure.
Medical Research Institute of New Zealand firmographics
Firmographics- Name
- Medical Research Institute of New Zealand
- Legal name
- Medical Research Institute of New Zealand
- Website
- https://mrinz.ac.nz
- Company type
- Private
- Founded year
- 2001
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- MRINZ is an independent, non-profit clinical research organisation based in Wellington, New Zealand, founded in 2001. It conducts investigator-initiated clinical trials in respiratory medicine, critical care, infectious diseases, and stroke rehabilitation across 11 countries, funded by the Health Research Council of New Zealand, Cure Kids, and industry partners.
- Ownership category
- akta.pro rank
Medical Research Institute of New Zealand industry classification
Industry- Product category
- Clinical Research Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical Trial Monitoring Support (On-site/Remote) (HLAGACAG)
- akta.pro secondary industries
- Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM), Clinical Quality Assurance (GCP QA, TMF/QMS oversight) (HLAGAKAI), Healthcare Outcomes & Real-World Evidence (RWE) Analytics (BPAHALAN)
Keywords
Where Medical Research Institute of New Zealand is headquartered
LocationHeadquarters
- HQ city
- Wellington
- HQ country
- New Zealand
- HQ region
- Oceania
Markets served
Medical Research Institute of New Zealand business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Others
Distribution channels1 record
Marketing channels5 records
Medical Research Institute of New Zealand product offering
Product offeringCore offering
The Medical Research Institute of New Zealand (MRINZ) is an independent, registered charity that conducts investigator-initiated and collaborative clinical trials across respiratory medicine (asthma, COPD), critical care, infectious diseases, stroke rehabilitation, and Māori and Pacific health. It delivers high-quality peer-reviewed evidence published in leading journals and integrated into international treatment guidelines, and operates research infrastructure such as the Pharmacy Research Network (PRN) and the free Take Charge stroke rehabilitation intervention.
Product overview
The MRINZ is an independent non-profit medical research institute focused on clinical research rather than commercial products. Their core offerings include clinical trial research programmes across multiple therapeutic areas (asthma, critical care, stroke, infectious diseases, respiratory health) and research infrastructure such as the Pharmacy Research Network. The Take Charge Stroke Rehabilitation Intervention is a free patient-centred rehabilitation tool available online. The research institute collaborates with healthcare providers, universities, and international research organisations to conduct clinical trials and deliver evidence-based healthcare findings.
Differentiator
Problem solved
Functional benefit
Products and services
- Take Charge Stroke Rehabilitation Intervention A patient-centred rehabilitation approach using simple images and prompts that focuses on an individual's thoughts, goals and support network, rather than being directed by health professionals. Available free to download in multiple languages and used alongside conventional therapy for stroke rehabilitation.
- Pharmacy Research Network (PRN) A network of 25 research-trained pharmacies across New Zealand, founded and managed by MRINZ in partnership with the New Zealand Pharmacy Guild, enabling community pharmacy-led research studies.
- Investigator-Initiated Clinical Trials Clinical trials across multiple therapeutic areas including respiratory medicine (asthma, COPD), critical care, infectious diseases, stroke rehabilitation, and Māori and Pacific People's Health. Delivered in collaboration with public hospitals and international research networks.
Quantifiable outcome
- 45% reduction in childhood asthma attacks with budesonide/formoterol reliever therapy vs salbutamol
- +4 more outcomes
Companies that use Medical Research Institute of New Zealand
Customer profileSegments2 records
Ideal customer profiles3 records
Medical Research Institute of New Zealand technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Medical Research Institute of New Zealand partnerships and signals
Strategic signalScale indicators10 records
Recent moves6 records
Expansion highlights6 records
Medical Research Institute of New Zealand competitors and assessment
Company assessmentBroad incumbents
- Population Health Research Institute (McMaster): Large Canadian academic clinical-research body running mega-trials at global scale. Comparable in investigator-initiated mega-trial expertise, although significantly larger and broader in therapeutic coverage than MRINZ.
Others
- Cure Kids: NZ children's health research charity that funds MRINZ programmes. Functions as a key funding partner rather than direct peer, but materially comparable as an NZ-based health-research charity ecosystem participant.
- Fisher & Paykel Healthcare: NZ-headquartered medical device company and MRINZ industry partner on respiratory and oxygen-therapy research. Adjacent rather than competing; relevant as a commercialisation channel for research outputs like the Airvo 3 titration findings.
Direct peers
- George Institute for Global Health: Independent global medical research institute with major programmes in critical care and large-scale international trials. Highly comparable to MRINZ in scale, investigator-initiated mega-trial focus, and global clinical-research footprint.
- MRC Clinical Trials Unit at UCL: UK-based academic clinical trials unit running large multi-country trials in infectious diseases and critical care. Comparable to MRINZ's REMAP-CAP and Mega-ROX investigator-initiated mega-trial activities and methodology focus.
- Baker Heart and Diabetes Institute: Independent Australian medical research institute delivering investigator-initiated clinical trials and translational research. Similar non-profit, charity-funded model with comparable headcount and publication output.
- NHMRC Clinical Trials Centre (University of Sydney): Academic clinical trials centre coordinating investigator-initiated and collaborative trials across multiple therapeutic areas. Comparable to MRINZ in trial coordination role, collaborative networks, and treatment-guideline evidence generation.
- Malaghan Institute of Medical Research: Independent New Zealand-based biomedical research institute focused on immunology and infectious disease. Comparable as another charity-funded, non-profit research organisation operating in Wellington/NZ with similar scale and grant-driven model.
- Liggins Institute (University of Auckland): NZ-based clinical research institute within the University of Auckland focused on translational medicine and clinical trials. Overlaps with MRINZ on investigator-initiated trials, NZ grant funding ecosystem, and multi-therapeutic research programmes.
Emerging players
- Berry Consultants: Statistics and trial-design firm specialising in adaptive platform trials. Overlaps with MRINZ's Mega-ROX adaptive ICU trial design and could be a methodological peer or collaborator on future platform trials.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Medical Research Institute of New Zealand social profiles
Digital presenceMedical Research Institute of New Zealand financial estimates
Financial estimateRevenue estimate
Valuation estimate
Medical Research Institute of New Zealand leadership team
Management profileNumber of profiles
Profiles17 records
Medical Research Institute of New Zealand funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Medical Research Institute of New Zealand M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Medical Research Institute of New Zealand
What does Medical Research Institute of New Zealand do?
The Medical Research Institute of New Zealand (MRINZ) is an independent, registered charity that conducts investigator-initiated and collaborative clinical trials across respiratory medicine (asthma, COPD), critical care, infectious diseases, stroke rehabilitation, and Māori and Pacific health. It delivers high-quality peer-reviewed evidence published in leading journals and integrated into international treatment guidelines, and operates research infrastructure such as the Pharmacy Research Network (PRN) and the free Take Charge stroke rehabilitation intervention.
Is Medical Research Institute of New Zealand a public or private company?
Medical Research Institute of New Zealand is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Medical Research Institute of New Zealand founded?
Medical Research Institute of New Zealand was founded in 2001. It employs 11 to 50 people.
Where is Medical Research Institute of New Zealand based?
Medical Research Institute of New Zealand is headquartered in Wellington, New Zealand, in the Oceania region.
Who are Medical Research Institute of New Zealand's main competitors?
Population Health Research Institute (McMaster) is listed as a broad incumbent. Others are Cure Kids and Fisher & Paykel Healthcare. Direct peers are George Institute for Global Health, MRC Clinical Trials Unit at UCL, Baker Heart and Diabetes Institute, NHMRC Clinical Trials Centre (University of Sydney), Malaghan Institute of Medical Research and Liggins Institute (University of Auckland). Berry Consultants is listed as an emerging player.
Does Medical Research Institute of New Zealand have an API?
No public API is recorded for Medical Research Institute of New Zealand.
What industry is Medical Research Institute of New Zealand in?
Medical Research Institute of New Zealand's product category is Clinical Research Services. Its primary akta.pro industry code is HLAGACAG, Clinical Trial Monitoring Support (On-site/Remote), with a secondary code of HLAJAOAM, Global Health Research, Clinical Trials & Product Development Partnerships (PDPs). Its NAICS code is 5417 and its SIC code is 8731.